New Report: Effects of COVID-19 on the Federal Research and Development Enterprise

The Congressional Research Service (CRS) has released a report, 'The Effects of COVID-19 on the Federal Research Enterprise'.

'...This report provides an overview of how the nation’s response to COVID-19 is affecting the federal R&D enterprise, how the federal government and others are addressing those effects, and issues that may arise as the situation develops. The scope of this report is limited to the effects of COVID-19 on federally funded R&D. It does not attempt to address effects on the broader U.S. R&D enterprise, the majority of which is funded by and conducted in the private sector. In addition, it does not attempt to address the federal R&D resources now being focused on understanding the science of COVID-19, developing tests and treatments, and otherwise applying R&D to address the pandemic...'

The full report (PDF) is available here and here.